Daxor (DXR) vs QTREX Quantum (QTEX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
QTREX Quantum (QTEX) has outperformed Daxor (DXR) over the past year, gaining 9.3% versus a loss of 43.5%. Over five years, DXR leads with a -32.3% price change compared with -69.7% for QTEX. QTREX Quantum is the larger company by market cap ($70.6 million vs $43.5 million), about 1.6 times the size.
Daxor converts more of its revenue into profit, with a net margin of -496.8% versus -4574.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXR | QTEX |
|---|---|---|
| Share price | $7.45 | $1.00 |
| Market cap | $43.49M | $70.63M |
| 1-day change | -7.33% | -10.71% |
| YTD return | -49.49% | +11.11% |
| 1-year return | -43.52% | +9.29% |
| 5-year return | -32.27% | -69.70% |
| P/E ratio (TTM) | 6.77 | — |
| EPS (TTM) | $1.10 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.45M | $289.00K |
| Revenue growth (YoY) | -8.42% | — |
| Net income (latest FY) | $-7.19M | $-13.22M |
| Gross margin | 54.89% | 0.69% |
| Operating margin | -400.07% | -4713.84% |
| Net margin | -496.81% | -4574.39% |
| 52-week high | $14.76 | $3.85 |
| 52-week low | $6.94 | $0.283 |
| Distance from 52-week high | -49.53% | -74.03% |
| Analyst consensus | none | none |
| Avg. price target upside | +168.46% | +400.00% |
| Average volume | 22.43K | 9.21M |
| Shares outstanding | 5.84M | 70.63M |
| Employees | — | 34 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QTEX has outperformed DXR by 52.8 percentage points over the past year.
- Daxor is more profitable, keeping -496.8 cents of every revenue dollar as net income versus -4574.4 cents for QTREX Quantum.
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
About QTREX Quantum
QTEX stock →QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
Health Care · Medical/Dental Instruments · 34 employees
DXR vs QTEX FAQ
Which is bigger, Daxor or QTREX Quantum?
QTREX Quantum (QTEX) is larger, with a market capitalization of $70.63M compared with $43.49M for Daxor (DXR).
Which stock has performed better over the past year, DXR or QTEX?
QTEX returned +9.29% over the past 12 months, compared with -43.52% for DXR (price return, excluding dividends). Past performance does not predict future results.
Are Daxor and QTREX Quantum in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.